Željka Večerić-Haler Matjaž Sever Nika Kojc Philip F Halloran Emanuela Boštjančič Gregor Mlinšek Manca Oblak Primož Poženel Urban Švajger Katrina Hartman Miomir Kneževič Ariana Barlič Lenart Girandon Andreja Aleš Rigler Samo Zver Jadranka Buturović Ponikvar Miha Arnol
10.3389/ti.2022.10772
Transpl Int
2022 Nov 22;35:10772.
antibody mediated rejection kidney allograft kidney transplant mesenchymal stem cells stem cells
CC BY
https://pubmed.ncbi.nlm.nih.gov/36484064/
Graft Rejection Mesenchymal Stem Cells
Graft Rejection Mesenchymal Stem Cells Clinical Trial, Phase II Clinical Trial, Phase I Humans Kidney
PMC9722440
36484064
Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series
2022